跳至主要内容
临床试验/NCT04024631
NCT04024631招募中不适用

Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes

University of Pennsylvania4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
4
主要终点
Glucose response to an oral glucose load

研究概览

简要总结

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

详细描述

The study team will recruit individuals based on genetic risk score for type 2 diabetes from the biobank populations who have agreed to be recontacted for future research. Each participant will undergo a frequently sampled four-hour oral glucose tolerance test and whole body DXA scan (dual-energy X-ray absorptiometry) in addition to baseline laboratory and history assessment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

Data analyses (including by outcomes assessors and investigators) will be de-identified, and individuals performing laboratory analyses and DXA interpretation will be blinded to polygenic risk score for type 2 diabetes. Participants and nursing staff will not be informed of polygenic risk score at the time of the study.

入排标准

年龄范围
10 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 10-70 years
  • Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research.
  • Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher

排除标准

  • prior diagnosis of type 1, type 2, or secondary diabetes
  • use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication
  • acute illness that may impact insulin and glucose dynamics
  • pregnancy
  • hypothalamic obesity or related genetic disorder of metabolism
  • recent systemic chemotherapy use
  • gastrointestinal impairment or surgery that may impact absorption
  • major organ system illness or any underlying condition requiring regular medication or treatment that could make implementation of the protocol or interpretation of the study results difficult
  • inability to comply with study protocol

结局指标

主要结局

Glucose response to an oral glucose load

时间窗: samples will be collected over four hours and these results will be used to calculate area under the curve

Glucose area under the curve after the 75g glucose beverage

次要结局

  • Disposition index(samples will be collected over four hours after the 75g glucose beverage and these results will be used for mixed modeling)
  • Visceral adiposity index(DXA scan will be obtained on the same day as the oral glucose test and will be completed in less than 30 minutes)
  • HOMA-IR(calculated from baseline fasting insulin and glucose levels)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jessica R.Wilson, MD, MS

Instructor in Medicine

University of Pennsylvania

研究点 (4)

Loading locations...

相似试验

Phenotyping Genetic Risk for Type 2 Diabetes | 临床试验